The Potential Clinical and Economic Outcomes of Pharmacogenomic Approaches to EGFR-Tyrosine Kinase Inhibitor Therapy in Non-Small-Cell Lung Cancer.

Saved in:
Bibliographic Details
Title: The Potential Clinical and Economic Outcomes of Pharmacogenomic Approaches to EGFR-Tyrosine Kinase Inhibitor Therapy in Non-Small-Cell Lung Cancer.
Authors: Carlson JJ (AUTHOR), Garrison LP (AUTHOR), Ramsey SD (AUTHOR), Veenstra DL (AUTHOR)
Source: Value in Health. Jan/Feb2009, Vol. 12 Issue 1, p20-27. 8p.
Database: Academic Search Ultimate
Description
ISSN:10983015
DOI:10.1111/j.1524-4733.2008.00415.x